1 octubre 2015
Researchers are calling on the medical community to reconsider developing a known drug to treat people with relapsing multiple sclerosis (MS) after new evidence shows it does not increase the risk of cancer as previously thought.
http://www.sciencedaily.com/releases/2015/10/151001165018.htm
